Liquidia Technologies, Inc. (LQDA) Social Stream

Liquidia Technologies, Inc. (LQDA)

Today's Latest Price: $6.22 USD

0.14 (2.30%)

Updated Aug 7 12:00am

Add LQDA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Featured Post From StockTwits About LQDA

$LQDA Why would UTHR mention LQDA in the earnings call?

United Therapeutics files amended patent infringement complaint on Liquidia United Therapeutics (UTHR) announced the United States Patent and Trademark Office issued a new patent on relating to Tyvaso Inhalation Solution. The new patent, U.S. Patent No. 10,716,793, expires May 14, 2027, and is listed in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations publication, also known as the Orange Book, for Tyvaso. Yesterday, United Therapeutics filed an amended complaint against Liquidia Technologies (LQDA) in its pending patent infringement litigation in the U.S. District Court for the District of Delaware to include a claim for infringement of this new patent.
SeedF, published August 6, 2020

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5342 seconds.